MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

Abstract Background Stereotactic body radiotherapy (SBRT) is an established local treatment method for patients with hepatic oligometastasis or oligoprogression. Liver metastases often occur in close proximity to radiosensitive organs at risk (OARs). This limits the possibility to apply sufficiently...

Full description

Bibliographic Details
Main Authors: P. Hoegen, K. S. Zhang, E. Tonndorf-Martini, F. Weykamp, S. Regnery, P. Naumann, K. Lang, J. Ristau, S. A. Körber, C. Dreher, C. Buchele, C. Rippke, C. K. Renkamp, K. M. Paul, L. König, C. Büsch, J. Krisam, O. Sedlaczek, H.-P. Schlemmer, M. Niyazi, S. Corradini, J. Debus, S. Klüter, J. Hörner-Rieber
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Radiation Oncology
Subjects:
Liver metastases
Stereotactic body radiotherapy (SBRT)
MR-guided radiotherapy
MR-Linac
MRI
ITV
Online Access:https://doi.org/10.1186/s13014-022-02033-2

Similar Items

Similar Items